HARY.CN Harrys Manufacturing Inc. CNQ up 58% 14 Mar 2026: watch volume and outlook

HARY.CN stock surged 58.33% to C$0.095 during market hours on 14 Mar 2026. The move came on a volume spike of 1,156,860 shares, well above the average 214,654. Traders priced a big short-term shift into the tobacco micro-cap. We look at what drove the gain, the fundamentals under the move, and the risk profile for Canadian-listed Harrys Manufacturing Inc. on CNQ.

HARY.CN stock: intraday move and volume drivers

Harrys Manufacturing Inc. (HARY.CN) opened at C$0.065 and hit a day high of C$0.105 on heavy buying. Volume was 1,156,860, a relative volume of 5.39, signaling abnormal participation. The stock closed around C$0.095, up C$0.035 from the prior close of C$0.06. This intraday surge classifies HARY.CN among market hours top gainers on 14 Mar 2026.

HARY.CN stock: fundamentals and valuation snapshot

Harrys Manufacturing lists on CNQ in Canada with a market cap near C$10,807,105.00 and 113,759,000 shares outstanding. Trailing EPS is -0.01 with a PE of -9.50, reflecting losses. Price averages are 50-day C$0.060 and 200-day C$0.029, showing a sharp run from prior levels. The company sits in the Consumer Defensive tobacco industry, where sector peers show far higher scale and cleaner margins.

HARY.CN stock: technicals show strong trend, neutral momentum

Short-term indicators are mixed. RSI sits at 43.17, signaling neutral momentum, while ADX at 31.54 points to a strong trend. Bollinger Bands run roughly C$0.05–C$0.10, and on-balance volume (OBV) rose sharply with today’s trade. The 50-day average has crossed above the 200-day average in recent months, supporting momentum despite low float and high volatility.

HARY.CN stock: Meyka AI grade and analyst context

Meyka AI rates HARY.CN with a score out of 100: 73.10 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating balances rapid recent gains against weak liquidity and negative profitability metrics. These grades are informational and not financial advice.

HARY.CN stock: forecasts, price targets and model projection

Meyka AI’s forecast model projects monthly C$0.03, quarterly C$0.08, and five-year C$0.05356 targets. Versus the current C$0.095, the quarterly model implies a short-term downside near -15.79% and the five-year view implies -43.62%. We present a conservative price target of C$0.03, a base case of C$0.08, and a bull case of C$0.12. Forecasts are model-based projections and not guarantees.

HARY.CN stock: catalysts, liquidity and risk points

Near-term catalysts include the earnings announcement on 2026-03-30 and any licensing or distribution updates. Liquidity remains a concern given the tiny market cap and volatile float. Key risks include negative book value, thin current ratio, and regulatory pressure on tobacco. For competitor context see Investing.com comparison and macro commentary at WSJ.

Final Thoughts

HARY.CN stock’s 58.33% jump to C$0.095 on 14 Mar 2026 was volume-driven and places the micro-cap squarely among top gainers for the session. Fundamentals remain weak: EPS -0.01, PE -9.50, and a market cap of roughly C$10,807,105.00. Technicals show a strong trend but neutral momentum, and liquidity risk is material given the low float and high relative volume. Meyka AI’s forecast model projects a quarterly target of C$0.08, implying about -15.79% from today’s price. We present a conservative target of C$0.03, a base of C$0.08, and a bull scenario at C$0.12. Investors should weigh the stock’s speculative upside against regulatory, liquidity, and earnings risks. Meyka AI, an AI-powered market analysis platform, flags HARY.CN as a high-volatility micro-cap where active risk management matters. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.